Barclays
HURA

Barclays’s TuHURA Biosciences HURA Stock Holding History

Barclays’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.5K Sell
9,241
-43,374
-82% -$53.2K ﹤0.01% 4611
2025
Q4 		$39.8K Buy
52,615
+15,725
+43% +$30.1K ﹤0.01% 4774
2025
Q3 		$91.5K Sell
36,890
-11,394
-24% -$30K ﹤0.01% 4641
2025
Q2 		$108K Buy
+48,284
New +$163K ﹤0.01% 4549
2020
Q3 		– Sell
-21
Closed -$25K – 5653
2020
Q2 		$25K Sell
21
-30
-59% -$38.4K ﹤0.01% 5153
2020
Q1 		$36K Hold
51
– – ﹤0.01% 5405
2019
Q4 		$62K Buy
+51
New +$55K ﹤0.01% 5680
2019
Q2 		– Sell
-4
Closed -$35K – 7341
2019
Q1 		$35K Buy
4
+1
+33% +$6.79K ﹤0.01% 6108
2018
Q4 		$17K Buy
+3
New +$29.1K ﹤0.01% 5980

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return